A final mechanism by which hyperlipidemia could impact osteoblast performance and skeletal homeostasis is through the activation of PPARγ, a transcriptional regulator of adipogenesis that can be activated by elevated lipid levels. The gene discussed is PPARG; the disease is hyperlipidemia.